"Over 27 million people in the U.S. suffer from OA, of whom approximately 13.5 million suffer from both OA and hypertension"
If we get only 3 mil out of 13.5 mil people using our drug, 3 mil x 365 days = almost $1 bil revenue. Assume only 50% margin = $500m net. Divides 8m shares = $62.5. Dont even talking about PE. I am happy with 62.5. Remember this is only in the US market. Add the EU market....hmmm :)